The Asia-Pacific market for Magnesium Acetate Tetrahydrate has entered in a new phase of pricing behaviour in early April and reflected a shift in the demand of end-users. In March the prices saw an increase across key APAC markets like China and India whereas in April the trend diverged sharply. This opposing trend has drawn attention from pharmaceutical and nutraceutical manufacturers who rely heavily on consistent pricing for Magnesium Acetate Tetrahydrate in their formulations. The shift is primarily driven by internal adjustments in China which is a key manufacturing hub for Magnesium Acetate Tetrahydrate. There was also a decrease in raw material costs and the leftover stocks from previous production cycles led suppliers to revise their pricing strategy.
The decline in cost of raw material like acetic acid in China contributed to softening of Magnesium Acetate Tetrahydrate prices. The drop in acetic acid prices reduced the...
